Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012) - Fig 1

<p>Fig 1A: Prevalence of transmitted drug resistance mutations by study period and drug family according to the 2009 WHO list. Fig 1B: Prevalence of non-B HIV-1 subtypes and immigrants by study period. Footnote figure: NRTI indicates nucleoside reverse transcriptase inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor; PI, protease inhibitor.